Tracidol

Tracidol Side Effects

tramadol

Manufacturer:

Y.S.P. Industries

Distributor:

Y.S.P. Industries
Full Prescribing Info
Side Effects
The most commonly reported undesirable effects caused by the medicinal product are nausea and dizziness, which both appear in over 10% of the patients.
Disorders of the digestive system: Very common (>10%): nausea. Common (1-10%): emesis, constipation, drying of the mouth. Uncommon (<1%): vomiting, irritation of the digestive system (sense of pressure in the stomach, bloating). Rare (<0.1%): change in appetite.
Disorders in connection with the heart and arteries: Uncommon (<1%): cardiovascular regulation (palpitation, tachycardia, hypotension in connection with posture or cardiovascular collapse). These undesirable effects may be found especially in patients who are physically over-strained. Rare (<0.1 %): bradycardia, increase in blood pressure.
Disorders of the central and peripheral nervous system: Very common (>10%): dizziness. Common (1-10%): headache, incoherence. Rare (<0.1%): respiratory depression. If the recommended dosages are considerably exceeded and simultaneously given with other compounds that affect the central nervous system, a respiratory depression may occur. Seizures resembling epilepsy occurred mainly after large doses of Tramadol had been administered or when the patient had been simultaneously treated with medicinal products which may reduce the seizure threshold, or, as such, cause cerebral convulsions, numbness, trembling, and changes in appetite.
Psychiatric disorders: Rare (<0.1%): psychic side effects may occur after the administration of Tramadol and there may occur individual variations of the strength and the character of the adverse effects (depending on the personality and the duration of the medication). Changes in mood (usually elation, occasionally dysphoria), changes in activity (usually suppression, sporadically increases) and changes in the cognitive and sensory capabilities (for example decision making, disorders of perception), hallucinations, confusion, sleep disturbances and nightmares.
Very rare (<0.01%): addiction, abuse and withdrawal symptoms may occur. Withdrawal symptoms may be: agitation, anxiety, nervousness, insomnia, hyperkinesias, tremors and disorders of the digestive system.
The majority of these are very similar to those occurring in connection with opiate withdrawal.
Visual disorders: Rare (<0.1%): blurred vision.
Respiratory disorders: Rare (<0.1%): dyspnoea and wheezing.
Exacerbation of asthma has also been reported, although the causality has not been established.
Skin and appendages disorders: Common (1-10%): sweating.
Uncommon (<1%): skin reactions (for example itching, rash, urticaria).
Musculo-Skeletal system disorders: Rare: (<0.1%): motor weakness.
Liver and biliary system disorders: In a few isolated cases an increase in liver enzymes has been reported in connection with a temporary therapeutic use of Tramadol.
Urinary system disorders: Rare (<0.1%): urinary disorders (difficulties in passing urine and urinary retention).
Body as whole: Rare (<0.1%): allergic reactions (for example dyspnoea, bronchospasms, wheezing, angioneurotic oedema and anaphylaxis).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in